Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

Nature

Volumn 409, Issue 6817, 2001, Pages 207-211

  Soengas, María S ^a   Capodieci, Paola ^b   Polsky, David ^b   Mora, Jaume ^b   Esteller, Manel ^c   Opitz Araya, Ximena ^a   McCombie, Richard ^a   Herman, James G ^c   Gerald, William L ^b   Lazebnik, Yuri A ^a   Cordón Cardó, Carlos ^b   Lowe, Scott W ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CASPASE 9; CYTOCHROME C; PROTEIN P53;

ALLELISM; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; CASPASES; CHROMOSOMES, HUMAN, PAIR 12; CLONING, MOLECULAR; DNA METHYLATION; DNA, NEOPLASM; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MUTATION; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035843169     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35051606     Document Type: Article

References (29)

1. Malignant melanoma: Modern black plague and genetic black box
2. The chemoresistance of human malignant melanoma: An update
3. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
4. Apoptosis and therapy
5. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
6. Differential requirement for caspase 9 in apoptotic pathways in vivo
7. Oncogene-dependent apoptosis is mediated by caspase-9
8. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
9. DNA methylation: Past, present and future directions
10. Methylation-induced repression - Belts, braces, and chromatin
11. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus
12. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
13. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
14. Mitochondria and apoptosis
15. Caspase-9 and APAF-1 form an active holoenzyme
16. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
17. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase- 9 activation and apoptosis
18. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
19. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype
20. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
21. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
22. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
23. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
24. Inhibition of death receptor signals by cellular FLIP
25. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
26. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome Arm 1p
27. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
28. Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein
29. Automated in situ hybridization: Diagnostic and research applications